ANALYSIS OF THE CONDITION OF PATIENTS WITH METABOLIC DISEASES AND HYPERTENSION

Abstract

Hypertension (HT) is one of the most widespread and serious global health problems, characterized by a persistent increase in blood pressure. In recent decades, significant attention has been paid to the impact of metabolic diseases on the course and prognosis of hypertension. Hypertension is often accompanied by metabolic abnormalities such as dyslipidemia, impaired glucose metabolism, and obesity, increasing the risk of cardiovascular complications.

The aim of this article is to systematize existing knowledge about metabolic diseases in hypertensive patients, analyze the underlying mechanisms of their interaction, and discuss promising research directions in this field. The research methods include an analysis of the latest scientific publications and review articles available in medical databases.

The results of the analysis emphasize the importance of early detection and effective management of metabolic diseases in hypertensive patients. Dyslipidemia, insulin resistance, and obesity have a significant impact on the course of hypertension and increase the risk of cardiovascular complications. Particular attention is paid to the underlying mechanisms of the interconnections between these conditions, which is essential for developing personalized approaches to treatment and prevention.

In conclusion, it is emphasized that more research is needed to develop new methods for the diagnosis, prevention, and treatment of metabolic diseases in hypertensive patients. Optimizing the management of metabolic factors can significantly reduce the burden of disease and improve the prognosis for patients suffering from hypertension and concomitant metabolic disorders.